Flunisolide
生产企业:Roche palo alto llc, Acton pharmaceuticals inc,另有 5 家
Flunisolide is an inhaled corticosteroid used as a prophylactic therapy in the maintenance treatment of asthma.
Flunisolide is an inhaled corticosteroid used as a prophylactic therapy in the maintenance treatment of asthma.
Flunisolide is a glucocorticoid receptor agonist. The antiinflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. The immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Flunisolide binds to plasma transcortin, and it becomes active when it is not bound to transcortin.
For the maintenance treatment of asthma as a prophylactic therapy.
共 2 项相关疾病